Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-08

Clinical Trial Update: Nuedexta for the Treatment of Adults With Autism [Phase 2]

View source ↗

Summary

Phase 2 trial results for Nuedexta in adults with autism have been posted following completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: Sutter Health | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2017-12-08